top of page

MOU signed between Grasshopper Air Mobility and Dronpharma

Press Release

16 Jul 2025

Grasshopper Air Mobility and Dronpharma Sign Strategic MoU to Advance Drone-Based Pharmaceutical Logistics

Barcelona, Spain, July 14th 2025 – Grasshopper Air Mobility and Dronpharma have signed a Memorandum of Understanding to strengthen their collaboration on the development and deployment of autonomous drone logistics solutions for the pharmaceutical sector.


The agreement builds on an already active relationship between the two companies, including an LOI from Dronpharma over 5 units, shared speaker engagements at Barcelona New Economy Week 2024 and SIL 2025, as well as a joint application to the CDTI NEOTEC public funding call. With this MoU, both parties reaffirm their commitment to jointly developing efficient, scalable, and fully traceable cold-chain delivery solutions via autonomous aerial technologies.


The collaboration will focus on identifying Dronpharma’s operational needs, testing key use cases with a small-scale proof-of-concept vehicle and jointly applying for public innovation funding to accelerate deployment. Grasshopper contributes its expertise in autonomous, (fly-drive) drone technology, while Dronpharma brings sectoral know-how and logistics infrastructure tailored to the pharmaceutical industry.


###

About Grasshopper Air Mobility Grasshopper Air Mobility is a drone manufacturer headquartered in Barcelona, Spain with the mission to enable aerial logistics for all companies through advanced aerial mobility solutions.  To learn more, visit www.grasshopperairmobility.com


About Dronpharma Dronpharma Vant SL is a company based at the airport of Teruel, Spain focused on drone-based logistics, specifically for the pharmaceutical industry. It's a joint venture between Delsat International, a drone operator, and Novaltia Soc. Cooperativa, Spain’s sixth largest pharmaceutical distributor. The company aims to develop and implement drone delivery solutions for last-mile pharmaceutical distribution. To learn more, visit www.pharmadron.es 


Contact

bottom of page